Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 4/20 | 0.48 |
| ▸ | CA9 | Q16790 | 4/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1999533 | 0.92 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL3530288 | 0.90 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL26162772 | 0.85 | CA12 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL24186174 | 0.85 | ALOX15 (0.47) | ALOX15TSHRHIF1ALMNATDP1 | |
| SCHEMBL11956572 | 0.85 | TSHR (0.69) | CA12CA1CA2CA7CA9 | |
| Chelidamic Acid SCHEMBL743778 | 0.83 | ALOX15 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7078655 | 0.83 | ALOX15 (0.45) | ALOX15TSHRHIF1ALMNATDP1 | |
| SCHEMBL400775 | 0.83 | MAPT (0.50) | ALOX15TSHRHIF1ALMNATDP1 | |
| SCHEMBL6391471 | 0.83 | NQO2 (0.50) | ALOX15TSHRHIF1ALMNATDP1 | |
| SCHEMBL30643514 | 0.83 | MAPT (0.50) | ALOX15TSHRHIF1ALMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025031383-A1 | BIFUNCTIONAL LINKER COMPOUND, ANTIBODY DRUG CONJUGATE, PREPARATION METHOD FOR ANTIBODY DRUG CONJUGATE, AND USE OF ANTIBODY DRUG CONJUGATE | 杭州爱科瑞思生物医药有限公司 | 2025-02-13 | — | — | WO | disclosed |
| CN-117069793-A | Bifunctional linker compound, antibody drug conjugate, and preparation methods and applications thereof | 杭州爱科瑞思生物医药有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-111378144-A | Force-induced response supramolecular polymer | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| US-7964878-B2 | Light emitting polymer devices using self-assembled monolayer structures | HCF PARTNERS, LP (US) | 2011-06-21 | — | — | US | disclosed |
| US-20100134052-A1 | Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures | HCF PARTNERS, L.P. (US) | 2010-06-03 | — | — | US | disclosed |
| WO-2006116584-A2 | LIGHT EMITTING POLYMER DEVICES USING SELF-ASSEMBLED MONOLAYER STRUCTURES | DYNAMIC ORGANIC LIGHT, INC. (US) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100134052-A1 | Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures | CLTB, CYBA, CLTA | CA12 2379/4885CA1 3166/4885CA2 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.